iarc newsletter
Donate now

Nutrition and Metabolism Branch (NME)



  1. Loftfield E, Stepien M, Viallon V, Trijsburg L, Rothwell J, Robinot N, et al. (2021). Novel biomarkers of habitual alcohol intake and associations with risk of pancreatic and liver cancers and liver disease mortality. J Natl Cancer Inst. (in press)
  2. Murphy N, Carreras-Torres R, Song M, Chan AT, Martin RM, Papadimitriou N, et al. (2020). Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associated with risk of colorectal cancer based on serologic and Mendelian randomization analyses. Gastroenterology. 158(5):1300–12.e20. https://doi.org/10.1053/j.gastro.2019.12.020 PMID:31884074
  3. Murphy N, Cross AJ, Abubakar M, Jenab M, Aleksandrova K, Boutron-Ruault MC, et al. (2016). A nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med. 13(4):e1001988. https://doi.org/10.1371/journal.pmed.1001988 PMID:27046222
  4. Aglago EK, Huybrechts I, Murphy N, Casagrande C, Nicolas G, Pischon T, et al. (2020). Consumption of fish and long-chain n-3 polyunsaturated fatty acids is associated with reduced risk of colorectal cancer in a large European cohort. Clin Gastroenterol Hepatol. 18(3):654–666.e6. https://doi.org/10.1016/j.cgh.2019.06.031 PMID:31252190
  5. Deschasaux M, Huybrechts I, Julia C, Hercberg S, Egnell M, Srour B, et al. (2020). Association between nutritional profiles of foods underlying Nutri-Score front-of-pack labels and mortality: EPIC cohort study in 10 European countries. BMJ. 370:m3173. https://doi.org/10.1136/bmj.m3173 PMID:32938660
  6. Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, et al. (2020). Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 18(1):5. https://doi.org/10.1186/s12916-019-1474-7 PMID:31918762
  7. His M, Biessy C, Torres-Mejía G, Ángeles-Llerenas A, Alvarado-Cabrero I, Sánchez GI, et al.; PRECAMA team (2020). Anthropometry, body shape in early-life and risk of premenopausal breast cancer among Latin American women: results from the PRECAMA study. Sci Rep. 10(1):2294. https://doi.org/10.1038/s41598-020-59056-6 PMID:32042008
  8. Murphy N, Knuppel A, Papadimitriou N, Martin RM, Tsilidis KK, Smith-Byrne K, et al. (2020). Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women. Ann Oncol. 31(5):641–9. https://doi.org/10.1016/j.annonc.2020.01.066 PMID:32169310
  9. Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, et al. (2020). Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 11(1):597. https://doi.org/10.1038/s41467-020-14389-8 PMID:32001714
  10. Rothwell JA, Murphy N, Bešević J, Kliemann N, Jenab M, Ferrari P, et al. (2020). Metabolic signatures of healthy lifestyle patterns and colorectal cancer risk in a European cohort. Clin Gastroenterol Hepatol. S1542-3565(20)31635-9. https://doi.org/10.1016/j.cgh.2020.11.045 PMID:33279777
  11. Wedekind R, Kiss A, Keski-Rahkonen P, Viallon V, Rothwell JA, Cross AJ, et al. (2020). A metabolomic study of red and processed meat intake and acylcarnitine concentrations in human urine and blood. Am J Clin Nutr. 112(2):381–8. https://doi.org/10.1093/ajcn/nqaa140 PMID:32492168
  12. His M, Viallon V, Dossus L, Gicquiau A, Achaintre D, Scalbert A, et al. (2019). Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med. 17(1):178. https://doi.org/10.1186/s12916-019-1408-4 PMID:31547832
  13. Keski-Rahkonen P, Kolehmainen M, Lappi J, Micard V, Jokkala J, Rosa-Sibakov N, et al. (2019). Decreased plasma serotonin and other metabolite changes in healthy adults after consumption of wholegrain rye: an untargeted metabolomics study. Am J Clin Nutr. 109(6):1630–9. https://doi.org/10.1093/ajcn/nqy394 PMID:31136658
  14. Mullee A, Romaguera D, Pearson-Stuttard J, Viallon V, Stepien M, Freisling H, et al. (2019). Association between soft drink consumption and mortality in 10 European countries. JAMA Intern Med. 179(11):1479–90. https://doi.org/10.1001/jamainternmed.2019.2478 PMID:31479109
  15. Assi N, Gunter MJ, Thomas DC, Leitzmann M, Stepien M, Chajès V, et al. (2018). Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort. Am J Clin Nutr. 108(1):117–26. https://doi.org/10.1093/ajcn/nqy074 PMID:29924298
  16. Chajès V, Assi N, Biessy C, Ferrari P, Rinaldi S, Slimani N, et al. (2017). A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study. Ann Oncol. 28(11):2836–42. https://doi.org/10.1093/annonc/mdx482 PMID:28950350
  17. Gunter MJ, Murphy N, Cross AJ, Dossus L, Dartois L, Fagherazzi G, et al. (2017). Coffee drinking and mortality in 10 European countries: a multinational cohort study. Ann Intern Med. 167(4):236–47. https://doi.org/10.7326/M16-2945 PMID:28693038
  18. Stepien M, Keski-Rahkonen P, Kiss A, Robinot N, Duarte-Salles T, Murphy N, et al. (2021). Metabolic perturbations prior to hepatocellular carcinoma diagnosis: findings from a prospective observational cohort study. Int J Cancer. 148(3):609–25. https://doi.org/10.1002/ijc.33236 PMID:32734650
  19. Neveu V, Nicolas G, Salek RM, Wishart DS, Scalbert A (2020). Exposome-Explorer 2.0: an update incorporating candidate dietary biomarkers and dietary associations with cancer risk. Nucleic Acids Res. 48(D1):D908–12. https://doi.org/10.1093/nar/gkz1009 PMID:31724701
  20. Romieu I, Biessy C, Joffe M, Cubasch H, Norris S, Vorster HH, et al. (2021). Reproductive factors and risk of breast cancer in black South African women. Cancer Causes Control. 32(4):415–22. https://doi.org/10.1007/s10552-021-01390-9 PMID:33471235


Close Reading Mode